Molecular Stethoscope, Inc., a San Diego, CA-based biotechnology company developing novel blood-based early detection.
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 7, 2022 | Grant | — | 1 | ADDF's Diagnostics Accelerator | — | Detail |
Jan 5, 2017 | Seed | $8.19M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ADDF's Diagnostics Accelerator | Yes | Grant |
Pfizer | — | Seed |